The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD

Abstract Chronic kidney disease (CKD)–mineral bone disorder (CKD‐MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD‐MBD is unknown. To determine the effect of f...

Full description

Bibliographic Details
Main Authors: Annabel Biruete, Neal X. Chen, Corinne E. Metzger, Shruthi Srinivasan, Kalisha O'Neill, Paul B. Fallen, Austin Fonseca, Hannah E. Wilson, Henriette deLoor, Pieter Evenepoel, Kelly S. Swanson, Matthew R. Allen, Sharon M. Moe
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:JBMR Plus
Subjects:
Online Access:https://doi.org/10.1002/jbm4.10837
_version_ 1797384929296777216
author Annabel Biruete
Neal X. Chen
Corinne E. Metzger
Shruthi Srinivasan
Kalisha O'Neill
Paul B. Fallen
Austin Fonseca
Hannah E. Wilson
Henriette deLoor
Pieter Evenepoel
Kelly S. Swanson
Matthew R. Allen
Sharon M. Moe
author_facet Annabel Biruete
Neal X. Chen
Corinne E. Metzger
Shruthi Srinivasan
Kalisha O'Neill
Paul B. Fallen
Austin Fonseca
Hannah E. Wilson
Henriette deLoor
Pieter Evenepoel
Kelly S. Swanson
Matthew R. Allen
Sharon M. Moe
author_sort Annabel Biruete
collection DOAJ
description Abstract Chronic kidney disease (CKD)–mineral bone disorder (CKD‐MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD‐MBD is unknown. To determine the effect of fiber on CKD‐MBD, we fed the Cy/+ rat with progressive CKD a casein‐based diet of 0.7% phosphate with 10% inulin (fermentable fiber) or cellulose (non‐fermentable fiber) from 22 weeks to either 30 or 32 weeks of age (~30% and ~15% of normal kidney function; CKD 4 and 5). We assessed CKD‐MBD end points of biochemistry, bone quantity and quality, cardiovascular health, and cecal microbiota and serum gut‐derived uremic toxins. Results were analyzed by two‐way analysis of variance (ANOVA) to evaluate the main effects of CKD stage and inulin, and their interaction. The results showed that in CKD animals, inulin did not alter kidney function but reduced the increase from stage 4 to 5 in serum levels of phosphate and parathyroid hormone, but not fibroblast growth factor‐23 (FGF23). Bone turnover and cortical bone parameters were similarly improved but mechanical properties were not altered. Inulin slowed progression of aorta and cardiac calcification, left ventricular mass index, and fibrosis. To understand the mechanism, we assessed intestinal microbiota and found changes in alpha and beta diversity and significant changes in several taxa with inulin, together with a reduction in circulating gut derived uremic toxins such as indoxyl sulfate and short‐chain fatty acids. In conclusion, the addition of the fermentable fiber inulin to the diet of CKD rats led to a slowed progression of CKD‐MBD without affecting kidney function, likely mediated by changes in the gut microbiota composition and lowered gut‐derived uremic toxins. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
first_indexed 2024-03-08T21:46:47Z
format Article
id doaj.art-21450129c6b94e78a48768ce1ab0b5a8
institution Directory Open Access Journal
issn 2473-4039
language English
last_indexed 2024-03-08T21:46:47Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series JBMR Plus
spelling doaj.art-21450129c6b94e78a48768ce1ab0b5a82023-12-20T07:51:27ZengWileyJBMR Plus2473-40392023-12-01712n/an/a10.1002/jbm4.10837The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKDAnnabel Biruete0Neal X. Chen1Corinne E. Metzger2Shruthi Srinivasan3Kalisha O'Neill4Paul B. Fallen5Austin Fonseca6Hannah E. Wilson7Henriette deLoor8Pieter Evenepoel9Kelly S. Swanson10Matthew R. Allen11Sharon M. Moe12Department of Nutrition Science Purdue University West Lafayette IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USADepartment of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USADepartment of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USAKU Leuven Department of Microbiology and Immunology Nephrology and Renal Transplantation Research Group, KU Leuven Leuven BelgiumKU Leuven Department of Microbiology and Immunology Nephrology and Renal Transplantation Research Group, KU Leuven Leuven BelgiumDepartment of Animal Sciences University of Illinois at Urbana‐Champaign Urbana IL USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USADepartment of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN USAAbstract Chronic kidney disease (CKD)–mineral bone disorder (CKD‐MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD‐MBD is unknown. To determine the effect of fiber on CKD‐MBD, we fed the Cy/+ rat with progressive CKD a casein‐based diet of 0.7% phosphate with 10% inulin (fermentable fiber) or cellulose (non‐fermentable fiber) from 22 weeks to either 30 or 32 weeks of age (~30% and ~15% of normal kidney function; CKD 4 and 5). We assessed CKD‐MBD end points of biochemistry, bone quantity and quality, cardiovascular health, and cecal microbiota and serum gut‐derived uremic toxins. Results were analyzed by two‐way analysis of variance (ANOVA) to evaluate the main effects of CKD stage and inulin, and their interaction. The results showed that in CKD animals, inulin did not alter kidney function but reduced the increase from stage 4 to 5 in serum levels of phosphate and parathyroid hormone, but not fibroblast growth factor‐23 (FGF23). Bone turnover and cortical bone parameters were similarly improved but mechanical properties were not altered. Inulin slowed progression of aorta and cardiac calcification, left ventricular mass index, and fibrosis. To understand the mechanism, we assessed intestinal microbiota and found changes in alpha and beta diversity and significant changes in several taxa with inulin, together with a reduction in circulating gut derived uremic toxins such as indoxyl sulfate and short‐chain fatty acids. In conclusion, the addition of the fermentable fiber inulin to the diet of CKD rats led to a slowed progression of CKD‐MBD without affecting kidney function, likely mediated by changes in the gut microbiota composition and lowered gut‐derived uremic toxins. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.https://doi.org/10.1002/jbm4.10837BONECARDIOVASCULARCKD‐MINERAL BONE DISORDERDIETARY FIBERINULIN
spellingShingle Annabel Biruete
Neal X. Chen
Corinne E. Metzger
Shruthi Srinivasan
Kalisha O'Neill
Paul B. Fallen
Austin Fonseca
Hannah E. Wilson
Henriette deLoor
Pieter Evenepoel
Kelly S. Swanson
Matthew R. Allen
Sharon M. Moe
The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
JBMR Plus
BONE
CARDIOVASCULAR
CKD‐MINERAL BONE DISORDER
DIETARY FIBER
INULIN
title The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
title_full The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
title_fullStr The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
title_full_unstemmed The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
title_short The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD
title_sort dietary fiber inulin slows progression of chronic kidney disease mineral bone disorder ckd mbd in a rat model of ckd
topic BONE
CARDIOVASCULAR
CKD‐MINERAL BONE DISORDER
DIETARY FIBER
INULIN
url https://doi.org/10.1002/jbm4.10837
work_keys_str_mv AT annabelbiruete thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT nealxchen thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT corinneemetzger thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT shruthisrinivasan thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT kalishaoneill thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT paulbfallen thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT austinfonseca thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT hannahewilson thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT henriettedeloor thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT pieterevenepoel thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT kellysswanson thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT matthewrallen thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT sharonmmoe thedietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT annabelbiruete dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT nealxchen dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT corinneemetzger dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT shruthisrinivasan dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT kalishaoneill dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT paulbfallen dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT austinfonseca dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT hannahewilson dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT henriettedeloor dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT pieterevenepoel dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT kellysswanson dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT matthewrallen dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd
AT sharonmmoe dietaryfiberinulinslowsprogressionofchronickidneydiseasemineralbonedisorderckdmbdinaratmodelofckd